Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 14564011
[patent_doc_number] => 20190209612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => Method
[patent_app_type] => utility
[patent_app_number] => 16/188185
[patent_app_country] => US
[patent_app_date] => 2018-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17304
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16188185
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/188185 | Method of preparing T cells with increased activity | Nov 11, 2018 | Issued |
Array
(
[id] => 14403837
[patent_doc_number] => 20190167762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => EFFICIENT SYSTEMIC TREATMENT OF DYSTROPHIC MUSCLE PATHOLOGIES
[patent_app_type] => utility
[patent_app_number] => 16/185248
[patent_app_country] => US
[patent_app_date] => 2018-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13731
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16185248
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/185248 | Efficient systemic treatment of dystrophic muscle pathologies | Nov 8, 2018 | Issued |
Array
(
[id] => 16506503
[patent_doc_number] => 20200385759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => INTRACELLULAR DELIVERY METHOD
[patent_app_type] => utility
[patent_app_number] => 16/474996
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24294
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16474996
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/474996 | Intracellular delivery method | Nov 1, 2018 | Issued |
Array
(
[id] => 13955629
[patent_doc_number] => 20190054158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => COMPOSITIONS AND METHODS FOR THE TREATMENT OF AADC DEFICIENCY
[patent_app_type] => utility
[patent_app_number] => 16/179116
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53533
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16179116
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/179116 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF AADC DEFICIENCY | Nov 1, 2018 | Abandoned |
Array
(
[id] => 14639417
[patent_doc_number] => 10364441
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-30
[patent_title] => Methods tip assemblies and kits for introducing material into cells
[patent_app_type] => utility
[patent_app_number] => 16/159185
[patent_app_country] => US
[patent_app_date] => 2018-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 37
[patent_no_of_words] => 20718
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16159185
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/159185 | Methods tip assemblies and kits for introducing material into cells | Oct 11, 2018 | Issued |
Array
(
[id] => 14806423
[patent_doc_number] => 20190269821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => Delivery Scaffolds and Related Methods of Use
[patent_app_type] => utility
[patent_app_number] => 16/154269
[patent_app_country] => US
[patent_app_date] => 2018-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16154269
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/154269 | Delivery Scaffolds and Related Methods of Use | Oct 7, 2018 | Abandoned |
Array
(
[id] => 16648781
[patent_doc_number] => 10925935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-23
[patent_title] => Terminally Modified RNA
[patent_app_type] => utility
[patent_app_number] => 16/152945
[patent_app_country] => US
[patent_app_date] => 2018-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 149674
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16152945
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/152945 | Terminally Modified RNA | Oct 4, 2018 | Issued |
Array
(
[id] => 14564201
[patent_doc_number] => 20190209707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => NEURONAL SPECIFIC TARGETING OF CAVEOLIN EXPRESSION TO RESTORE SYNAPTIC SIGNALING AND IMPROVE COGNITIVE FUNCTION IN THE NEURODEGENERATIVE BRAIN AND MOTOR FUNCTION IN SPINAL CORD
[patent_app_type] => utility
[patent_app_number] => 16/141645
[patent_app_country] => US
[patent_app_date] => 2018-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22622
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16141645
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/141645 | Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord | Sep 24, 2018 | Issued |
Array
(
[id] => 14069413
[patent_doc_number] => 20190083594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => AQUAPORIN TOLERIZING VACCINES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/130774
[patent_app_country] => US
[patent_app_date] => 2018-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16130774
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/130774 | AQUAPORIN TOLERIZING VACCINES AND METHODS OF USE THEREOF | Sep 12, 2018 | Abandoned |
Array
(
[id] => 18517664
[patent_doc_number] => 11707535
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Method and composition for treating neuropathic pain
[patent_app_type] => utility
[patent_app_number] => 16/638972
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 41
[patent_no_of_words] => 14673
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638972
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/638972 | Method and composition for treating neuropathic pain | Sep 6, 2018 | Issued |
Array
(
[id] => 14016565
[patent_doc_number] => 20190070276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => Use of Car and Bite Technology Coupled with an SCFV from an Antibody Against Human Thymidine Kinase 1 to Specifically Target Tumors
[patent_app_type] => utility
[patent_app_number] => 16/122557
[patent_app_country] => US
[patent_app_date] => 2018-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16122557
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/122557 | Use of car and bite technology coupled with an SCFV from an antibody against human thymidine kinase 1 to specifically target tumors | Sep 4, 2018 | Issued |
Array
(
[id] => 14099267
[patent_doc_number] => 20190091309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => Use of Car and Bite Technology Coupled with an SCFV from an Antibody Against Human Thymidine Kinase 1 to Specifically Target Tumors
[patent_app_type] => utility
[patent_app_number] => 16/122563
[patent_app_country] => US
[patent_app_date] => 2018-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16122563
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/122563 | Use of car and bite technology coupled with an ScFv from an antibody against human thymidine kinase 1 to specifically target tumors | Sep 4, 2018 | Issued |
Array
(
[id] => 14016567
[patent_doc_number] => 20190070277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => Use of Car and Bite Technology Coupled with an SCFV from an Antibody Against Human Thymidine Kinase 1 to Specifically Target Tumors
[patent_app_type] => utility
[patent_app_number] => 16/122564
[patent_app_country] => US
[patent_app_date] => 2018-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3191
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16122564
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/122564 | Use of car and bite technology coupled with an SCFV from an antibody against human thymidine kinase 1 to specifically target tumors | Sep 4, 2018 | Issued |
Array
(
[id] => 14019403
[patent_doc_number] => 20190071695
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => MICROFLUIDIC LASER-ACTIVATED INTRACELLULAR DELIVERY SYSTEMS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/115140
[patent_app_country] => US
[patent_app_date] => 2018-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16115140
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/115140 | Microfluidic laser-activated intracellular delivery systems and methods | Aug 27, 2018 | Issued |
Array
(
[id] => 17119844
[patent_doc_number] => 11130968
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-28
[patent_title] => High throughput assay for measuring adenovirus replication kinetics
[patent_app_type] => utility
[patent_app_number] => 16/109513
[patent_app_country] => US
[patent_app_date] => 2018-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 11842
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16109513
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/109513 | High throughput assay for measuring adenovirus replication kinetics | Aug 21, 2018 | Issued |
Array
(
[id] => 14210615
[patent_doc_number] => 20190117692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => ENGAGER CELLS FOR IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 16/109615
[patent_app_country] => US
[patent_app_date] => 2018-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24340
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16109615
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/109615 | ENGAGER CELLS FOR IMMUNOTHERAPY | Aug 21, 2018 | Abandoned |
Array
(
[id] => 13590763
[patent_doc_number] => 20180346930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => BIOLOGICALLY ACTIVE SYNTHETIC NANOPARTICLE CONSTRUCTS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/102876
[patent_app_country] => US
[patent_app_date] => 2018-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9673
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16102876
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/102876 | BIOLOGICALLY ACTIVE SYNTHETIC NANOPARTICLE CONSTRUCTS AND METHODS OF USE THEREOF | Aug 13, 2018 | Abandoned |
Array
(
[id] => 17148440
[patent_doc_number] => 11141493
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-12
[patent_title] => Compositions and methods for treating CEP290-associated disease
[patent_app_type] => utility
[patent_app_number] => 16/053763
[patent_app_country] => US
[patent_app_date] => 2018-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 93
[patent_figures_cnt] => 93
[patent_no_of_words] => 121374
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16053763
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/053763 | Compositions and methods for treating CEP290-associated disease | Aug 1, 2018 | Issued |
Array
(
[id] => 14185363
[patent_doc_number] => 20190112386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => COMPOSITIONS AND METHODS FOR TUMOR TRANSDUCTION
[patent_app_type] => utility
[patent_app_number] => 16/052397
[patent_app_country] => US
[patent_app_date] => 2018-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12959
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16052397
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/052397 | Compositions and methods for tumor transduction | Jul 31, 2018 | Issued |
Array
(
[id] => 14759507
[patent_doc_number] => 10391132
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-27
[patent_title] => Oncolytic viral vectors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/047499
[patent_app_country] => US
[patent_app_date] => 2018-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 51
[patent_no_of_words] => 32764
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16047499
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/047499 | Oncolytic viral vectors and uses thereof | Jul 26, 2018 | Issued |